IP Library › Granted Patent US 9,987,254
Granted Patent B2
US 9,987,254 · App. 14/225,704 · Granted Jun 5, 2018

Ophthalmic composition for correcting presbyopia

Inventors: Jose Vincent Rodriguez Hernandez (Las Palmas de Gran Canaria, ES); Humberto Carreras Diaz (Las Palmas de Gran Canaria, ES)
Assignee: EUROCANARIAS OFTALMOLÓGICA, S.L.
A61K31/4178A61K9/0048A61K31/196
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,987,254
App. No.
14/225,704
Granted
Jun 5, 2018
Kind
B2
Abstract

Ophthalmic composition for the correction of presbyopia. Composition consisting of 2% Pilocarpine, characterized by being diluted to 1% with sterile Balanced Salt Solution (BSS), obtaining 1% pilocarpine (2.5 ml)+bromfenac, 1.8 mgrs of bromfenac (2.5 ml)+sterile Balanced Salt Solution (BSS) (2.5 ml), finally obtaining eye drops of 7.5 ml. It is also possible to obtain a 1.5% and 2% pilocarpine.

Claims (16)

1. A 7.5 ml sample of an ophthalmic composition for the correction of presbyopia consisting of

2.5 ml of 2% Pilocarpine, diluted to 1% with sterile Balanced Salt Solution;

2.5 ml of 1.8 mg. to 2.25 mg. of bromfenac; and

2.5 ml of sterile Balanced Salt Solution.

2. An ophthalmic composition for the correction of presbyopia, the composition comprising:

an admixture of pilocarpine;

bromfenac; and

a sterile balanced salt solution,

wherein a 7.5 ml sample of the composition includes:

0.3% to 2% pilocarpine;

1.8 mg to 2.25 mg of bromfenac; and

2.5 ml of a sterile balanced salt solution.

3. The ophthalmic composition of claim 2 , wherein the composition includes 1% to 2% pilocarpine.

4. The ophthalmic composition of claim 3 , wherein the composition includes 1.5% pilocarpine.

5. The ophthalmic composition of claim 2 , wherein pilocarpine is pilocarpine hydrochloride.

6. The ophthalmic composition of claim 2 , wherein the bromfenac is bromfenac sodium sesquihydrate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2018
From: HERNANDEZ, JOSE VINCENT RODRIGUEZ; DÍAZ, HUMBERTO CARLOS CARRERAS
To: EUROCANARIAS OFTALMOLÓGICA S.L.
Reel/Frame 047649/0173 →
Priority Claims (1)
ES 201301177 · Dec 21, 2013 · national
Continuity (1)
Related Publication 20150174105A1 · Jun 25, 2015